Exchange: NYSE
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:04 PM ET 5/24/2013
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.30 | 0.85 | -65.04 |
| EPS, GAAP | 0.34 | 0.78 | 0.78 |
| Consensus Estimate | 0.41 | 0.47 | -13.45 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 4.48 | 3.23 | 38.82 |
| EPS, GAAP | 3.75 | 3.02 | 24.17 |
| Consensus Estimate | 2.41 | 2.23 | 8.08 |
| ABT | Industry Average | |
| P/E (TTM) | 11.33 | NA |
| P/E (Forward) | 18.79 | NA |
| PEG Ratio | 1.52 | 20.55 |
| Price/Sales | 1.65 | 8.19 |
| Beta | 0.10 | 0.65 |
| 10:06 AM | 5/14/2013 | AbbVie, Alvine Pharma to Collaborate on Investigational Drug for Celiac Disease |
| 5:04 PM | 5/10/2013 | AbbVie Chief Scientific Officer John Leonard to Retire |
| 5/20/2013 | Closing Bell for Monday on Wall Street: Markets Open Lower, Bounce Once, Then Go Flat (24/7 Wall St) |
| 5/20/2013 | Top Analyst Upgrades and Stocks to Buy: J.C. Penney, Pandora, Priceline and More (24/7 Wall St) |
| 5/16/2013 | AbbVie Is Good Medicine (Barrons.com) |
| 5/7/2013 | Viagra for Sale Online: Will Other Drug Companies Follow Pfizer? (24/7 Wall St) |
| 5/6/2013 | The Top Seven Drugs with U.S. Quarterly Sales Over $1 Billion (24/7 Wall St) |
| 5/1/2013 | Pfizer Still an Easy Pill to Swallow (Barrons.com) |
| 4/30/2013 | Auction of Brazilian Drug Maker Stalls (WSJ.com) |
| 4/26/2013 | AbbVie Reports First Earnings Since IPO (24/7 Wall St) |
